FCH
CLDX icon

Freestone Capital Holdings’s Celldex Therapeutics CLDX Stock Holding History

Freestone Capital Holdings’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-670
Closed -$29K – 331
2017
Q3 		$29K Buy
+670
New +$29K ﹤0.01% 326